Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

XHEvsPBEETF Comparison

ETF 1
XHE

State Street SPDR S&P Health Care Equipment ETF

This fund is part of
US Health Care
+0.32%
VS
ETF 2
PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of
BioTech & Genomics
-2.11%

State Street SPDR S&P Health Care Equipment ETF (XHE) belongs to the US Health Care segment. Invesco Dynamic Biotechnology & Genome ETF (PBE) is part of the BioTech & Genomics segment. XHE's top 3 sector exposures are Healthcare and Finance. In contrast, PBE's top sector exposures are Healthcare  XHE is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.58% for PBE. XHE is down -3.04% year-to-date (YTD) with +$2M in YTD flows. PBE performs better with 10.25% YTD performance, and +$2M in YTD flows. Run a side-by-side ETF comparison of XHE and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XHE vs PBE performance and flow charts

Performance

0.02.04.06.08.0%Jun 24Jul 1Jul 9Jul 16Jul 23

Cumulative Flows

-2 M0 M2 M4 M6 MJun 24Jul 1Jul 9Jul 16Jul 23

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/24/2026
1M3MYTD1Y3Y5Y
Perf.
XHE
PBE
+3.29%+2.57%
+3.26%+13.26%
-3.04%+10.25%
+8.72%+37.00%
-12.17%+44.35%
-31.68%+23.92%
Flows
XHE
PBE
+$2M+$5M
+$26M+$4M
+$2M+$2M
-$18M-$17M
-$379M-$51M
-$397M-$45M
Volatility and drawdown
3M1Y3Y5Y
Volatility
XHE
PBE
+26.19%+18.74%
+22.63%+18.86%
+22.18%+20.25%
+24.70%+22.48%
Max drawdown
XHE
PBE
-6.40%-4.30%
-18.20%-11.70%
-32.21%-22.21%
-49.90%-34.74%
Max drawdown duration
XHE
PBE
43d17d
197d166d
1094d324d
1786d1540d
Trading data

Create an account to view trading data

Join for free
XHE
PBE
Last sale
7/27/2026 at 1:30 PM
$87.54
$89.85
Previous close
07/24/2026
$85.18
$89.59
Consolidated volume
07/24/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
XHE
PBE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/27/2026 at 1:30 PM
Live
Closed
XHE
PBE
Last price
$87.54
$89.85
1D performance
+2.77%
+0.29%
AuM$151.67 M$282.11 M
E/R0.35%0.58%
Characteristics
XHE
PBE
Management strategyPassivePassive
ProviderState Street Investment ManagementInvesco
BenchmarkS&P Health Care Equipment Select Industry IndexDynamic Biotech & Genome Intellidex Index
N° of holdings6730
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJanuary 26, 2011June 23, 2005
ESGNoNo
Advertisement
Exposure

Countries

XHE
USA
89.54%
Other
10.46%
PBE
USA
97.25%
Other
2.75%

Sectors

XHE
Healthcare
94.54%
Other
5.46%
PBE
Healthcare
100%
Other
-0%
Advertisement

Diversification

XHE

Total weight of top 15 holdings out of 15

26.73%
PBE

Total weight of top 15 holdings out of 15

60.29%

Top 15 holdings

Data as of June 30, 2026
XHE
Butterfly Network, Inc.
2.45%
QuidelOrtho Corp.
2.04%
Glaukos Corp.
1.79%
UFP Technologies, Inc.
1.79%
Axogen, Inc.
1.76%
Lantheus Holdings, Inc.
1.74%
Artivion, Inc.
1.73%
Envista Holdings Corp.
1.72%
Omnicell, Inc.
1.71%
Medline, Inc.
1.69%
Alphatec Holdings, Inc.
1.67%
Dentsply Sirona, Inc.
1.66%
Inspire Medical Systems, Inc.
1.66%
The Cooper Cos., Inc.
1.66%
Edwards Lifesciences Corp.
1.65%
PBE
Vertex Pharmaceuticals, Inc.
5.12%
Biogen, Inc.
5.08%
Amgen, Inc.
4.84%
Royalty Pharma Plc
4.74%
Regeneron Pharmaceuticals, Inc.
4.53%
Alnylam Pharmaceuticals, Inc.
4.48%
Gilead Sciences, Inc.
4.34%
United Therapeutics Corp.
4.26%
Bio-Techne Corp.
3.67%
Veracyte, Inc.
3.39%
CareDx, Inc.
3.31%
Vericel Corp.
3.27%
Repligen Corp.
3.16%
PTC Therapeutics, Inc.
3.09%
Protagonist Therapeutics, Inc.
3.02%
Frequently asked questions about XHE and PBE

How have the XHE and PBE ETFs performed in 2026?

As of July 24, 2026, XHE is down -3.04% year-to-date (YTD), while PBE has returned 10.25%. That puts PBE better performer ahead so far this year.

Which ETF is attracting more investor money: XHE or PBE?

Year-to-date, the XHE ETF saw +$2M in flows, compared to +$2M for PBE.

Which ETF is more volatile: XHE or PBE?

Over the past year, XHE had a volatility of 22.63%, while PBE experienced 18.86%.

Which ETF is bigger: XHE or PBE?

As of July 24, 2026, XHE holds $151.67 M in assets under management (AUM), while PBE manages $282.11 M.

What sectors do the XHE and PBE ETFs invest in?

XHE leans toward sectors like Healthcare. Meanwhile, PBE focuses on Healthcare.

What are the top holdings of the XHE ETF and PBE ETF?

XHE top holdings include Butterfly Network, Inc., QuidelOrtho Corp. and Glaukos Corp.. PBE holds in its top three: Vertex Pharmaceuticals, Inc., Biogen, Inc. and Amgen, Inc..

Which ETF is more diversified: XHE or PBE?

XHE holds 67 securities with 26.73% of its assets in the top 15. PBE has 30 securities and a top 15 weight of 60.29%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder